Alfred George, Jr., MD, is a pioneer in understanding the mechanisms by which ion channel mutations cause a variety of inherited disorders, such as genetic epilepsy. He discusses his recent breakthroughs in the field and his optimism for future RNA therapeutics to treat rare genetic diseases.
A chemical modification of messenger RNA (mRNA) performs different functions depending on its location, according to a study published in the journal Molecular Cell.
Northwestern Medicine continues to help advance the understanding of the COVID-19 pandemic and its widespread impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research to highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.
In the 2019-2020 academic year, the department’s consistent growth helped the medical school secure $407 million in awards from the National Institute of Health (NIH), and in the last fiscal year, the Department of Pharmacology was ranked seventh among U.S. departments of pharmacology in NIH funding.
Lakeside Discovery, LLC, the collaboration between Northwestern University and Deerfield Management, will support the laboratory of Paul DeCaen, PhD in a multi-year partnership to advance new therapies for genetically driven polycystic kidney disease.
Physician-Scientist Training & Resources
We offer a wide range of resources, mentorship opportunities and training to help our residents and fellows excel as physician-scientists. Explore all of the resources and hear from housestaff who are making research a major part of their career development plans.
Basic Science Administration
Our department is supported by the Basic Science Administration group. The team provides assistance related to research and financial administration, professional affairs, facilities and communications.